IGHVII-65-1 (4-65.1P): A Promising Drug Target for Cancer Treatment

Target Name: IGHVII-65-1

NCBI ID: G28359

IGHVII-65-1

Other Name(s): 4-65.1P | IGHVII651 | Immunoglobulin heavy variable (II)-65-1 (pseudogene) | immunoglobulin heavy variable (II)-65-1 (pseudogene) | IGHV(II)-65-1

IGHVII-65-1 (4-65.1P): A Promising Drug Target for Cancer Treatment

IGHVII-65-1 (4-65.1P) is a protein that is expressed in various tissues of the human body, including the liver, pancreas, and blood vessels. It is a member of the interleukin family, which is a group of cytokines that play a crucial role in the immune system.

IGHVII-65-1 (4-65.1P) has been shown to have a variety of functions in the immune system, including the regulation of inflammation and immune cell function. It is also involved in the regulation of cell death and has been shown to have anti-cancer properties.

As a drug target, IGHVII-65-1 (4-65.1P) is a promising target for the development of new treatments for a variety of diseases. Researchers are currently working to develop small molecules and other compounds that can inhibit the activity of IGHVII-65-1 (4-65.1P) and use it as a potential drug.

One approach that researchers are taking to develop new treatments for IGHVII-65-1 (4-65.1P) is to use small molecules that can inhibit the activity of the protein. These small molecules, which are called inhibitors, can be used to reduce the activity of IGHVII-65-1 (4-65.1P) to its normal level, which could potentially lead to the reversal of its cancer-promoting effects.

Another approach that researchers are taking to develop new treatments for IGHVII-65-1 (4-65.1P) is to use antibodies, which are proteins that are specifically designed to target and neutralize IGHVII-65-1 (4-65.1P). These antibodies can be used to block the activity of IGHVII-65-1 (4-65.1P) and reduce its cancer-promoting effects.

In addition to these approaches, researchers are also working to identify new biomarkers that can be used to monitor the activity of IGHVII-65-1 (4-65.1P). These biomarkers can be used to track the progress of the disease and to identify potential new treatments.

Overall, IGHVII-65-1 (4-65.1P) is a protein that is involved in a variety of functions in the immune system, including the regulation of inflammation and immune cell function. As a drug target, it is a promising target for the development of new treatments for a variety of diseases. Researchers are currently working to develop small molecules and other compounds that can inhibit the activity of IGHVII-65-1 (4-65.1P) and use it as a potential drug.

Protein Name: Immunoglobulin Heavy Variable (II)-65-1 (pseudogene)

The "IGHVII-65-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHVII-65-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets